Share

February 19, 2013; 80 (8) Contemporary Issues: Innovations in Education

Estimating and communicating prognosis in advanced neurologic disease

Robert G. Holloway, Robert Gramling, Adam G. Kelly
First published February 18, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318282509c
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
789

Share

Article Information

vol. 80 no. 8 764-772
DOI: 
https://doi.org/10.1212/WNL.0b013e318282509c
PubMed: 
23420894
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 11, 2012
  • Accepted September 19, 2012
  • First Published February 18, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Robert G. Holloway, MD, MPH,
    2. Robert Gramling, MD, DSc and
    3. Adam G. Kelly, MD
  1. Robert G. Holloway, MD, MPH,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor, Neurology Today, 2010

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Milliman Guidelines Inc., Consultant, Review neurologyguidelines, 2001-present

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH, 1U10NS077265-01, PI, 2011-2018NIH/NCRR 1 UL1 RR024160,1 KL2 RR024136-1, Director,Co-investigator 2011-2016NIH 5R01NS062770, Co-investigator 2009-2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Robert Gramling, MD, DSc and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Palliative Care Research Center

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Adam G. Kelly, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Donald W. Reynolds Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (R.G.H., A.G.K.) and Community and Preventive Medicine (R.G.H., R.G.), and Center for Ethics, Humanities, and Palliative Care (R.G.H., R.G.), Department of Family Medicine (R.G.), University of Rochester, NY.
  1. Correspondence to Dr. Holloway: robert_holloway{at}urmc.rochester.edu
View Full Text

Article usage

Article usage: February 2013 to May 2022

AbstractFullPdfSource
Feb 201310704475Highwire
Mar 20132543036Highwire
Apr 201312148Highwire
May 2013145213Highwire
Jun 201357512Highwire
Jul 20134235Highwire
Aug 20133975Highwire
Sep 20133564Highwire
Oct 20133936Highwire
Nov 20133128Highwire
Dec 20133442Highwire
Jan 20143434Highwire
Feb 20142812Highwire
Mar 20142434Highwire
Apr 20142100Highwire
May 20142412Highwire
Jun 20142332Highwire
Jul 20141822Highwire
Aug 20144301Highwire
Sep 20144642Highwire
Oct 20144312Highwire
Nov 20144402Highwire
Dec 20144321Highwire
Jan 20157522Highwire
Jan 20150169pmc
Feb 20154958Highwire
Feb 2015031pmc
Mar 20156417Highwire
Mar 20150176pmc
Apr 20154027Highwire
Apr 20150106pmc
May 20155011Highwire
May 20150124pmc
Jun 20155300Highwire
Jun 2015084pmc
Jul 20156801Highwire
Jul 20150206pmc
Aug 20156921Highwire
Aug 20150102pmc
Sep 20155011Highwire
Sep 20150175pmc
Oct 20154831Highwire
Oct 20150225pmc
Nov 20154421Highwire
Nov 20150204pmc
Dec 20155811Highwire
Dec 2015074pmc
Jan 20165211Highwire
Jan 20160163pmc
Feb 20162423Highwire
Feb 20160155pmc
Mar 20164202Highwire
Mar 20160174pmc
Apr 20163622Highwire
Apr 20160246pmc
May 20162021Highwire
May 2016051pmc
Jun 20163703Highwire
Jun 201604020pmc
Jul 20162511Highwire
Jul 20160182pmc
Aug 20162632Highwire
Aug 20160188pmc
Sep 20162101Highwire
Sep 20160187pmc
Oct 20162210Highwire
Oct 20160175pmc
Nov 20162213Highwire
Nov 20160214pmc
Dec 20162701Highwire
Dec 20160246pmc
Jan 20172961Highwire
Jan 20170307pmc
Feb 20171835Highwire
Feb 20170236pmc
Mar 20173021Highwire
Mar 20170277pmc
Apr 20171931Highwire
Apr 201752636pmc
May 20171912Highwire
May 201752224pmc
Jun 2017912Highwire
Jun 201731824pmc
Jul 20171235Highwire
Jul 201752019pmc
Aug 20171033Highwire
Aug 201772222pmc
Sep 20171523Highwire
Sep 201752124pmc
Oct 20171703Highwire
Oct 201763033pmc
Nov 2017401Highwire
Nov 201722426pmc
Dec 20172544Highwire
Jan 20183420Highwire
Feb 20182233Highwire
Mar 20182411Highwire
Apr 20182900Highwire
Apr 201851719pmc
May 20183433Highwire
Jun 20182700Highwire
Jun 201892218pmc
Jul 20182732Highwire
Aug 20181733Highwire
Aug 201892628pmc
Sep 20185841Highwire
Oct 20181800Highwire
Nov 20182511Highwire
Dec 20182900Highwire
Jan 20192023Highwire
Feb 20191622Highwire
Mar 20192832Highwire
Apr 20191020Highwire
May 20192610Highwire
Jun 2019300Highwire
Jul 20191610Highwire
Aug 20193414Highwire
Sep 20192311Highwire
Oct 20193199Highwire
Nov 20191112Highwire
Dec 20192514Highwire
Jan 20201222Highwire
Feb 20201021Highwire
Mar 20201300Highwire
Apr 20202221Highwire
May 20201631Highwire
Jun 20201231Highwire
Jul 2020712Highwire
Aug 20202101Highwire
Sep 20206820Highwire
Oct 20202924Highwire
Nov 20202721Highwire
Dec 20202221Highwire
Jan 20213041Highwire
Feb 20211430Highwire
Mar 20213042Highwire
Apr 20213430Highwire
May 20215353Highwire
Jun 20213252Highwire
Jul 20213431Highwire
Aug 20213252Highwire
Sep 20212443Highwire
Oct 20211933Highwire
Nov 20212911Highwire
Dec 20212722Highwire
Jan 20223102Highwire
Feb 20224751Highwire
Mar 20224334Highwire
Apr 20226862Highwire
May 20224874Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

  • Prognosticating early and accurately
    • Nitin K. Sethi, Assistant Professor of Neurology, New York-Presbyterian Hospital, Weill Cornell Medical Center 525 East 68th Street, New York, NY 1006
    • Nitin K Sethi, New York, NY
    Submitted March 07, 2013
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me